改良芍药甘草汤调控lncRNA H19/miR-185-5p/Tph1轴干预脊髓损伤后肌痉挛的机制研究OA
Modified Shaoyao Gancao decoction(芍药甘草汤)alleviates post-spinal cord injury muscle spasticity by regulating the lncRNA H19/miR-185-5p/Tph1 axis
目的:探讨改良芍药甘草汤干预脊髓损伤后肌痉挛的生物学机制.方法:①提取改良与原芍药甘草汤中的有效成分,采用色谱-质谱仪进行有效成分的测定,比较两者成分的差别.②40只SD大鼠,随机分为正常对照组、模型组、用药组和阳性对照组,每组10只.除正常对照组外其余大鼠采用T9-T10节段脊髓半横断法制作脊髓损伤大鼠模型,手术3d后正常对照组和模型组灌胃去离子水,用药组灌胃改良芍药甘草汤(芍药∶甘草=3∶1,每公斤体重3.3 g原生药),阳性对照组灌胃原芍药甘草汤(芍药∶甘草=1∶1,每公斤体重3.3 g原生药),共给药2周.通过BBB评分(Basso,Beattie & Bresnahan locomotor rating scale,BBB scale)观察药物疗效及检测脊髓组织 5-羟色胺(5-Hydroxytryptamine,5-HT)水平.采用聚合酶链式反应(polymerase chain reaction,RT-qPCR)观察模型组和用药组脊髓组织内长链非编码RNAH19(long noncoding RNA H19,lncRNA H19,以下简称 H19)和微小 RNA 185-5p(microRNA 185-5p,miR-185-5p)的表达.进而双荧光素酶报告基因实验验证H19调控miR-185-5p的表达及miR-185-5p调控色氨酸羟化酶1(tryptophan hydroxylase,Tph 1)的表达.③体外培养脊髓神经细胞,通过给予改良芍药甘草汤及H19 inhibitor(抑制剂)和miR-185-5p inhibitor观察药物和H19及miR-185-5p对Tph1表达的影响.④将12只SD大鼠随机分为模型组,用药组,H19 inhibitor组和阳性对照组,每组3只.H19 inhibitor组大鼠尾静脉注射H19 inhibitor 50 mg·kg-1,其余各组处理方法同①.酶联免疫法法测定5-HT的表达.结果:①总离子流图谱整体未呈现太大差异,但是改良的芍药甘草汤中芍药相关的化合物响应更高,甘草相关化合物响应降低.②给药2周后BBB评分用药组为(10.000±1.291)分,阳性对照组为(9.667±1.633)分,较模型组(3.286±0.756)分均有所提高(P<0.01,P<0.01),且 5-HT 表达用药组(7.097±1.414)pg·mL-1较模型组(5.144±0.904)pg·mL-1有所提高(P<0.01).RT-qPCR与Western blot实验结果显示给药后脊髓组织内H19与Tph1表达升高,而miR-185-5p表达下调;且双荧光素酶报告基因实验证实H19可以调控miR-185-5p的表达,而miR-185-5p则调控Tph1的表达.③培养的模型组脊髓细胞内Tph1表达较正常对照组下降,而用药组Tph1表达有所回升.H19 inhibitor组Tph1表达较正常对照组和用药组下降,而miR-185-5p inhibitor组Tph1表达较模型组和H19 in-hibitor 组有所升高.④进一步实验证明,用药组大鼠脊髓组织内5-HT呈现高表达状态,H19 inhibitor可以逆转这一现象.结论:芍药甘草汤通过调控H19/miR-185-5p/Tph1轴而促进神经递质5-HT合成的路径对脊髓损伤大鼠脊髓修复有积极作用.
Objective To investigate the biological mechanisms underlying the therapeutic effect of modified Shaoyao Gancao decoction(芍药甘草汤)in alleviating muscle spasms following spinal cord injury.Methods ①Extract and modify the active components from the original Shaoyao Gancao decoction(芍药甘草汤),determined their concentrations using chro-matography-mass spectrometry(HPLC-MS),and compared the differences between the two formulations.②Forty SD rats were randomly divided into four groups:normal control group,model group,treatment group,and positive control group,with 10 rats in each group.With the exception of the normal control group,all other rats were subjected to a spinal cord injury model via se-mi-transverse sectioning of the T9-T10segments.Three days post-surgery,the normal control group and the model group received oral administration of deionized water;the drug-treated group received oral administration of modified Shaoyao Gancao decoc-tion(芍药甘草汤),Shaoyao∶Gancao=3∶1,3.3 g of crude drugs per kg body weight;the positive control group received oral ad-ministration of Standard Shaoyao Gancao Decoction(Shaoyao∶Gancao=1∶1,3.3 g of crude drugs per kg body weight).The total treatment duration was 2 weeks.The drug efficacy was evaluated using the BBB scale(Basso,Beattie & Bresnahanlocomotor rating scale,BBB scale),and 5-hydroxytryptamine(5-HT)levels in spinal cord tissue were measured.The expression of long noncoding RNA H19(lncRNA H19,hereinafter referred to as H19)and microRNA 185-5p(miR-185-5p)in spinal cord tis-sues was examined using polymerase chain reaction(RT-qPCR)in both the model group and the treatment group.Furthermore,a dual-fluorescein enzyme reporter assay was employed to verify that H19 regulates the expression of miR-185-5p and that miR-185-5p,in turn,regulates the expression of tryptophan hydroxylase 1(Tph1).③In vitro culture of spinal cord nerve cells was conducted,where modified Shaoyao Gancao decoction(芍药甘草汤),H19inhibitor,and miR-185-5p inhibitor were adminis-tered to investigate the effects of these agents as well as H19 and miR-185-5p on Tph 1 expression.④Twelve SD rats were ran-domly divided into four groups:the model group,the drug administration group,the H19 inhibitor group,and the positive con-trol group,with three rats in each group.Rats in the H19 inhibitor group received intravenous injection of H19 inhibitor at a dose of 50 mg·kg-1 via the tail vein,while all other groups were treated as described in step ①.The expression levels of 5-HT were determined using enzyme-linked immunosorbent assay(ELISA).Results ①The overall ion current profile showed no sig-nificant differences;however,in the modified Shaoyao Gancao decoction(芍药甘草汤),compounds related to Paeonia exhib-ited higher responses,while those related to Glycyrrhiza demonstrated reduced responses.②At 2 weeks post-administration,the BBB score was 10.000±1.291 in the drug-treated group and 9.667±1.633 in the positive control group,both significantly higher than those in the model group 3.286±0.756(P<0.01).Additionally,5-HT expression levels were elevated in the drug-treated group(7.097±1.414)pg·mL-1 compared to the model group(5.144±0.904)pg·mL-1(P<0.01).RT-qPCR and Western blot results demonstrated increased expression of H19 and Tph1 in spinal cord tissue following administration,while miR-185-5p expression was downregulated.Dual-fluorescein reporter gene experiments further confirmed that H19 regulates miR-185-5p expression,which in turn modulates Tph1 expression.③In the cultured model group,Tph1 expression in spinal cord cells was lower than that in the normal control group,whereas it increased in the drug-treated group.In the H19 inhibitor group,Tph1 expression was reduced compared to both the normal control group and the drug-treated group;however,it was elevated in the miR-185-5p inhibitor group compared to both the model group and the H19 inhibitor group.④Further experiments demonstrat-ed that 5-HT exhibited high expression levels in the spinal cord tissues of rats in the drug-treated group,and the H19 inhibitor could reverse this phenomenon.Conclusion Shaoyao Gancao decoction(芍药甘草汤)exerts a positive effect on spinal cord repair in rats with spinal cord injury by modulating the H19/miR-185-5p/Tph1 axis,thereby promoting the synthesis of the neurotransmitter 5-HT.
乔一航;马文龙;周英杰;谢艳
河南中医药大学,河南 郑州 450046河南中医药大学,河南 郑州 450046||河南省洛阳正骨医院河南省骨科医院,河南 洛阳 471002河南省洛阳正骨医院河南省骨科医院,河南 洛阳 471002河南省洛阳正骨医院河南省骨科医院,河南 洛阳 471002
医药卫生
脊髓损伤肌肉痉挛中草药RNA,长链非编码微小RNAs色氨酸羟化酶5-羟色胺
Spinal cord injuriesMuscle spasticityDrug,Chinese herbalRNA,Long noncodingMicroRNAsTryptophan hydroxylase5-hydroxytryptamine
《中国骨伤》 2026 (8)
815-824,10
河南省中医药科学研究专项(编号:2019ZY1036)Henan Provincial Special Fund for Traditional Chinese Medicine Scientific Research(No.2019ZY1036)
评论